Top 5 Stocks to Buy According to Billionaire Investor Chris Rokos

In this article, we present the list of top 5 stocks to buy according to billionaire investor Chris Rokos. If you want to read our comprehensive analysis of  Rokos Capital Management’s history, investment philosophy, and hedge fund performance, go directly to the Top 10 Stocks to Buy According to Billionaire Investor Chris Rokos.

5. Bristol-Myers Squibb Company (NYSE:BMY)

Value of Rokos Capital’s 13F Position: $31.72 million

Number of Hedge Fund Shareholders: 67

Hedge fund ownership of Bristol-Myers Squibb Company (NYSE:BMY) has plummeted over the past year, falling by 59%. Chris Rokos’ was one of the exceptions to that trend, taking a 504,627-share stake in the pharmaceutical giant during Q4.

Bristol-Myers Squibb Company (NYSE:BMY) delivered 8% sales growth in Q4 on top of double-digit non-GAAP EPS gains, highlighted by the strong performance of blood clot medication Eliquis, sales of which climbed 20% year-over-year, and cancer treatment Opdivo, which was launched for new indications during the year and sales of which climbed 11%..

Bristol-Myers Squibb Company (NYSE:BMY) expects to launch three first-in-class medications in 2022, Mavacamten, deucravacitinib, and relatlimab, each of which the company believes could hit $4 billion in sales by 2029. The company is also in a very strong financial position, with $17 billion in cash and marketable securities at the end of 2021.